• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SCPH

SCPH

scPharmaceuticals Inc.

NASDAQHealthcareBiotechnologyUS

USD5.67

+0.00 (+0.00%)

Company Profile

CEO

John H. Tucker

IPO Date

2017-11-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$5.67

Prev. Close

$5.67

Day Low

$5.67

Day High

$5.67

52W Low

$1.94

52W High

$6.28

Market Cap

$0.30B

Volume

10.90M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

31.0%

Avg Negative

10.9%

Avg Neutral

58.4%

News Feed

scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study

GlobeNewsWire·7/13/2021·↑ positive

SCPH Stock Price Increases Over 18%: Why It Happened

Pulse2·7/1/2021·↑ positive

scPharmaceuticals Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

GlobeNewsWire·5/12/2021·↑ positive

scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D.

GlobeNewsWire·2/17/2021·↑ positive

scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference

GlobeNewsWire·2/11/2021·↑ positive

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of scPharmaceuticals Inc. - SCPH

PRNewsWire·12/10/2020·↓ negative

FDA Rejects scPharma's Heart Failure Drug For Second Time, Sending Biotech Stock Lower

Benzinga·12/7/2020·↓ negative

scPharmaceuticals to Present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference

GlobeNewsWire·11/19/2020·↑ positive

scPharmaceuticals Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

GlobeNewsWire·11/16/2020·↑ positive

scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

GlobeNewsWire·11/11/2020·↑ positive